Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Pharma
FDA signs off on expansion for GSK's Blujepa to treat gonorrhea
The FDA has signed off on a label expansion for GSK’s Blujepa, which brings an oral option and a new class of antibiotic treatment for gonorrhea.
Kevin Dunleavy
Dec 12, 2025 10:30am
Cidara snares BARDA award to boost R&D, production of flu asset
Oct 3, 2025 10:10am
AbbVie scores FDA nod for Pfizer-partnered antibiotic Emblaveo
Feb 10, 2025 8:09am
GSK, Sanofi, CSL nab BARDA funding for bird flu shots
Oct 4, 2024 1:35pm
CSL Seqirus picks up its 5th bird-flu-related BARDA award
Sep 26, 2024 3:50pm
Bavarian Nordic locks up $157M Jynneos supply pact with US
Aug 8, 2024 9:09am
